Diagnosis | Series | N | Mean Age (range) | Males (%) | ApoE4+ (%) |
---|---|---|---|---|---|
 | ALL | 2,193 | 74 (61-80) | 872 (40) | 1,539 (70) |
 | JS | 549 | 74 (61-80) | 212 (39) | 378 (69) |
 | RS | 291 | 74 (61-80) | 122 (42) | 201 (69) |
AD cases | AUT | 267 | 74 (61-80) | 139 (52) | 159 (60) |
 | NCRAD | 542 | 73 (61-80) | 199 (37) | 451 (83) |
 | PS | 378 | 75 (64-80) | 137 (36) | 226 (60) |
 | NW | 166 | 74 (61-80) | 63 (38) | 124 (75) |
 | ALL | 3,060 | 73 (60-80) | 1,404 (46) | 776 (25) |
 | JS | 650 | 73 (60-80) | 271 (42) | 200 (31) |
 | RS | 1,433 | 75 (60-80) | 720 (50) | 351 (24) |
Controls | AUT | 258 | 72 (61-80) | 158 (61) | 64 (25) |
 | NCRAD | 122 | 72 (61-80) | 48 (39) | 24 (20) |
 | PS | 164 | 72 (64-80) | 38 (23) | 33 (20) |
 | NW | 433 | 73 (61-80) | 169 (39) | 104 (24) |